Table 2. Characteristics of papers included in synthesis.
| Study design | Race | Gender | Cancer Locations/ Types |
Cancer Stage | Treatment | Age | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Study | Location | Cross-sectional | Longitudinal | Sample size | White | Non-White | Male | Female | Number specified when provided |
I-II | III-IV | Mets | Surgery | Chemotherapy | Radiation | Biologic agents | HSCT | min | max | mean |
| Anderson (2007) | US | 1 | 100 | 81 | 20 | 60 | 40 | H | 100 | 100 | 24 | 75 | 54 | |||||||
| Bevans, Mitchell, Marden (2008) | US | 1 | 76 | 35 | 41 | 51 | 25 | H | 76 | 76 | 18 | 71 | 40 | |||||||
| Chen ML, Chang HK (2004) | Taiwan | 1 | 121 | 66 | 55 | B= 48; D= 33; E= 40 | 18 | 60 | 43 | 26 | 81 | 52 | ||||||||
| Chen (2007) | Taiwan | 1 | 329 | 146 | 175 | A= 6; B= 93; C= 79; E= 57; H= 55; I= 24; L=7 | 77 | 197 | 173 | 233 | 22 | 97 | 61 | |||||||
| Ferreira (2008) | Brazil | 1 | 115 | 46 | 69 | B= 44; C= 6; E= 8; G= 15; I= 27; J= 12; L= 1 | 73 | 74 | 57 | 61 | 57 | |||||||||
| Gift (2004) | US | 1 | 220 | 200 | 20 | 130 | 90 | I | 84 | 136 | 92 | 95 | 139 | 65 | 89 | 72 | ||||
| Harding (2007) | US | 1 | 31 | 30 | 1 | 17 | 14 | G | 14 | 15 | 15 | 20 | 1 | 8 | 55 | |||||
| Hayes (2010) | Australia | 1 | 285 | 285 | B | 287 | 114 | 200 | 171 | 74 | 54 | |||||||||
| Hoffman (2007) | US | 1 | 80 | 76 | 4 | 44 | 36 | I | 1 | 67 | 41 | 83 | 63 | |||||||
| Karabulu (2010) | Turkey | 1 | 287 | 160 | 127 | B= 34; C= 113; E= 37; F= 15; H= 39; I= 49 | 197 | 90 | 51 | 274 | 73 | |||||||||
| Kenefick (2006) | US | 1 | 57 | 35 | 22 | 0 | 57 | B | 54 | 3 | 58 | |||||||||
| Keene Sarenmalm (2007) | Sweden | 1 | 54 | 0 | 54 | recurrent B | 32 | 24 | 10 | 7 | 42 | 55 | 79 | 65 | ||||||
| Kim (2008) | US | 1 | 282 | 258 | 24 | 0 | 282 | B | 220 | 31 | 125 | 157 | 30 | 83 | 50 | |||||
| Kiteley (2006) | Canada | 1 | 16 | 9 | 7 | I | 2 | 7 | 12 | 50 | 89 | 66 | ||||||||
| Nejmi (2010) | Moracco | 1 | 165 | 72 | 93 | B= 32; C= 35; E= 12; F= 25; G= 12; H= 4; I= 20; K= 6; L= 19 | 53 | 112 | 6 | 13 | 23 | 18 | 84 | 49 | ||||||
| Reyes-Gibby (2007) | US | 1 | 37 | 44 | 4 | 25 | 23 | C | 41 | 80 | 58 | |||||||||
| Shi (2010) | US | 1 | 42 | 25 | 17 | 10 | 32 | A, B, C, E, F, J | 19 | 23 | 19 | 60 | ||||||||
| Sun (2008) | US | 1 | 45 | 23 | 22 | 29 | 16 | C | 6 | 39 | 10 | 29 | 6 | 59 | ||||||
| Wang SY, et. al (2008) | Taiwan | 1 | 108 | 69 | 39 | I | 16 | 21 | 28 | 10 | 25 | 30 | 41 | 90 | 68 | |||||
| Wang (2010) | US, China, Japan, Russia, Korea | 1 | 1433 | 513 | 920 | Multicancer, not defined | 754 | 736 | ||||||||||||
| Wang XS, et. al (2010) | US | 1 | 184 | 146 | 38 | 87 | 97 | C&D | 31 | 85 | 10 | 112 | 25 | 20 | 84 | 60 | ||||
Cancer Type/Location: A= Brain/CNS ; B= Breast; C= Digestive/Gastrointestinal; D= Esophageal; E= Head & Neck; F= Gynecologic; G= Genitourinary/Renal; H= Hematologic; I= Lung; J= Prostate; K= stem; L= Other/Unknown